Abstract
A multiomics strategy that integrates metabolic and gene expression profiling in patient tumor samples and animal models identifies effective pharmacologic approaches to target rapidly proliferating breast tumor subtypes.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have